GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (OTCPK:CLSH) » Definitions » Median PS Value

CLS Holdings USA (CLS Holdings USA) Median PS Value : $0.00 (As of Jun. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is CLS Holdings USA Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. CLS Holdings USA's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was $0.262. CLS Holdings USA's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-06-05), CLS Holdings USA's share price is $0.055. CLS Holdings USA's Median PS Value is $0.00. Therefore, CLS Holdings USA's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for CLS Holdings USA's Median PS Value or its related term are showing as below:

CLSH's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.815
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

CLS Holdings USA Median PS Value Historical Data

The historical data trend for CLS Holdings USA's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Median PS Value Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CLS Holdings USA's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Price-to-Median-PS-Value falls into.



CLS Holdings USA Median PS Value Calculation

CLS Holdings USA's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.262*0
=0.00

10-Year Median PS Ratio is 0.
CLS Holdings USA's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.262.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CLS Holdings USA  (OTCPK:CLSH) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

CLS Holdings USA's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.055/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CLS Holdings USA Median PS Value Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (CLS Holdings USA) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Executives
Ross Silver director 516 SW 13TH STREET, SUITE 201, BEND OR 97702
Andrew Glashow director 1C BOWENS LANDING, NEWPORT RI 02840
Tribeca Investment Partners Pty Ltd 10 percent owner LEVEL 23, 1 O'CONNELL STREET, SYDNEY C3 2000
David Zelinger director C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Charlene Soco officer: Executive VP of Finance C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Chetan Gulati 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Todd V Swanson 10 percent owner 10120 W. FLAMINGO ROAD, #4333, LAS VEGAS NV 89147
Gregg E. Carlson officer: Chief Financial Officer 2342 MALAGA PEAK STREET, LAS VEGAS NV 89135
Navy Capital Green Management Llc 10 percent owner, other: See Remark(1) 482 BAYBERRY LANE, MOUNTAINSIDE NJ 07092
Navy Capital Green Co-invest Partners Llc 10 percent owner, other: See Remark(1) 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Co-invest Fund, Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Management Partners Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
John Kaden 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Sean Stiefel 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Fund, Lp 10 percent owner, other: See Remark(2) NAVY CAPITAL GREEN MANAGEMENT, LLC, 28 REICHERT CIRCLE, WESTPORT CT 06880